Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01590069 · ClinicalTrials.gov registry record · Phase 1

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

A Phase 1 study of Sarcoma and Metastatic Melanoma, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
Phase 1
Development phase
70
Enrollment target
1
Study location

NCT01590069 is a Phase 1 study of Sarcoma and Metastatic Melanoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 70 participants, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01590069, a Phase 1 study of Sarcoma and Metastatic Melanoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

This phase I/II trial studies the side effects and best dose of aerosolized aldesleukin and to see how well it works in treating patients with cancer that has spread from the original tumor to the lungs. Biological therapies, such as aerosolized aldesleukin, may stimulate or suppress the immune system in different ways and stop tumor cells from growing.

Conditions Studied

Sarcoma Metastatic Melanoma Stage IV Cutaneous Melanoma AJCC v6 and v7 Metastatic Malignant Neoplasm in the Lung Metastatic Osteosarcoma Stage IV Renal Cell Cancer AJCC v7 Metastatic Renal Cell Cancer Stage IV Osteosarcoma AJCC v7

Interventions

  • OTHER Laboratory Biomarker Analysis
  • BIOLOGICAL Aerosolized Aldesleukin

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2012-06-28
Est. Completion 2026-04-30
Phase Phase 1

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01590069

The ClinicalTrials.gov registry entry for NCT01590069 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (92% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Sarcoma appearing as the primary indexed condition, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.

NCT01590069 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01590069 about?

NCT01590069 is a clinical study titled "Aerosolized Aldesleukin in Treating Patients With Lung Metastases". This phase I/II trial studies the side effects and best dose of aerosolized aldesleukin and to see how well it works in treating patients with cancer that has spread from the original tumor to the lungs. Biological therapies, such as aerosolized aldesleukin, may stimulate or suppress the immune syst...

What is the current status of trial NCT01590069?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 70 participants. The study started on 2012-06-28. Estimated completion is 2026-04-30.

What conditions does trial NCT01590069 study?

This clinical trial studies the following conditions: Sarcoma, Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7, Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma.

What interventions are being tested in trial NCT01590069?

The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Aerosolized Aldesleukin (BIOLOGICAL).

Who is sponsoring clinical trial NCT01590069?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01590069 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sarcoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sarcoma

All registered trials for this condition

Metastatic Melanoma

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.